Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Liz Westcott Appointed Woodside CEO

businesswire.com
WDS XOM

Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending – Hagens Berman

globenewswire.com
TCOM

Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending – Hagens Berman

globenewswire.com
TCOM

BRBR 6-DAY DEADLINE ALERT: Hagens Berman Scrutinizing BellRing Brands (BRBR) Over Alleged Artificial Growth and $2.9 Billion Value Wipeout

globenewswire.com
BRBR

BRBR 6-DAY DEADLINE ALERT: Hagens Berman Scrutinizing BellRing Brands (BRBR) Over Alleged Artificial Growth and $2.9 Billion Value Wipeout

globenewswire.com
BRBR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tennant Company - TNC

globenewswire.com
TNC

Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions – Hagens Berman

globenewswire.com
SLNO

Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions – Hagens Berman

globenewswire.com
SLNO

Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

globenewswire.com
RVMD

QURE ALERT: FDA Reportedly Accuses uniQure of Pushing “Distorted” and “Manipulated” Data For “Failed” AMT-130 Drug Amid Pending Securities Class Action – Hagens Berman

globenewswire.com
QURE
View all news →